Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CT-868

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose

Carmot Therapeutics, Inc · Phase 1 · Completed · Enrollment 32

NCT04973111

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
CT-868n/rn/rn/rn/r
Placebon/rn/rn/rn/r
Active Comparatorn/rn/rn/rn/r

Not shown

  • CT-868: endpoint not reported
  • Placebo: endpoint not reported
  • Active Comparator: endpoint not reported